XML 26 R14.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 8 - Income Taxes
12 Months Ended
Dec. 31, 2021
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

8.

Income Taxes

 

Pre-tax loss consisted of the following (in thousands):  

 

  

Year Ended December 31,

 
  

2021

  

2020

 

U.S.

 $(820) $(851)

Foreign

  (1,422)  (1,038)

Total

 $(2,242) $(1,889)

 

Income tax expense consisted of the following (in thousands):

 

  

Year Ended December 31,

 
  

2021

  

2020

 

Current taxes:

        

Federal

 $  $ 

State and local

      

Foreign

      

Current taxes

      

Deferred taxes:

        

Federal

      

State and local

      

Foreign

      

Deferred taxes

      

Total

 $  $ 

 

Net deferred tax assets and liabilities consisted of the following (in thousands):  

 

  

December 31,

 
  

2021

  

2020

 

Deferred tax assets:

        

Net operating loss carryforwards

 $19,230  $18,141 

Research and development credit carryforwards

  2,747   3,058 

Stock-based compensation

  382   449 

Accrued expenses and reserves

  58   137 

Depreciation and amortization

     38 

Deferred revenue

  107   253 

Right of use liability

  318   357 

Other

  7   23 

Gross deferred tax assets

  22,849   22,456 

Less: valuation allowance

  (22,544)  (22,121)

Net deferred tax assets

  305   335 
         

Deferred tax liabilities:

        

Depreciation and amortization

  (16)   

Right of use asset

  (289)  (328)

Net deferred tax assets

 $  $7 

 

Net deferred tax assets and liabilities were recorded as follows (in thousands):  

 

  

December 31,

 
  

2021

  

2020

 

Deferred tax assets, non-current

 $  $7 

Deferred tax liability, non-current

      

Net deferred tax assets

 $  $7 

 

As of December 31, 2021, our deferred tax assets were primarily the result of U.S. net operating loss, research and development credit carryforwards and stock-based compensation expense. We have applied a full valuation allowance against the U.S. deferred tax assets in the U.S. and foreign jurisdictions.

 

We use judgment as to the appropriate weighting of all available evidence when assessing the need for the establishment or the release of valuation allowances. As part of this analysis, we examine all available evidence on a jurisdiction-by-jurisdiction basis and weigh the positive and negative information when determining the need for full or partial valuation allowances. The evidence considered for each jurisdiction includes, among other items, (i) the historical levels of income or loss over a range of time periods that extends beyond the two years presented, (ii) the historical sources of income and losses, (iii) the expectations and risk associated with underlying estimates of future taxable income, (iv) the expectations and risk associated with new product offerings and uncertainties with the timing of future taxable income, and (v) prudent and feasible tax planning strategies. Based on the analysis conducted as of December 31, 2021, we determined that we would maintain a full valuation allowance against our U.S. gross deferred tax assets.

 

The provision for income taxes differed from the amount of expected income tax expense determined by applying the applicable U.S. statutory federal income tax rate to pre-tax loss as follows (in thousands, except percentages):  

 

  

Year Ended December 31,

 
  

2021

  

2020

 

U.S. Federal tax benefit at statutory rates

 $(471)  21.0% $(397)  21.0%

Impact of:

                

Tax credits

        109   (5.8)

State income tax

  (83)  3.7   (53)  2.8 

International operations

  28   (1.3)  (6)  0.3 

Stock-based compensation

  93   (4.2)  317   (16.8)

Valuation allowance

  429   (19.1)  (1,224)  64.8 

Expiration of tax attributes

  311   (13.9)  1,330   (70.4)

PPP loan forgiveness

  (333)  14.9       

Other, net

  26   (1.1)  (76)  4.0 

Tax expense and effective tax rate

 $   0.0% $   0.0%

 

At December 31, 2021, we had approximately $83.7 million of federal and $12.8 million of state net operating loss carryforwards, which have begun to expire. Of the federal net operating loss carryforwards, approximately $62.7 million will expire by 2037 and $21.0 million are indefinite. We also have approximately $2.7 million of tax credit carryforwards, which have begun to expire. Use of these carryforwards may subject us to an annual limitation due to Section 382 of the U.S. Internal Revenue Code that restricts the ability of a corporation that undergoes an ownership change to use its carryforwards. Under the applicable tax rules, an ownership change occurs if holders of more than five percent of an issuer’s outstanding common stock, collectively, increase their ownership percentage by more than 50 percentage points over a rolling three-year period. We have performed analyses of possible ownership changes in the past, which included consideration of third-party studies, and do not believe that an ownership change of more than 50 percentage points has occurred.

 

We have evaluated all the material income tax positions taken on our income tax filings to various tax authorities, and we determined that we did not have unrealized tax benefits related to uncertain tax positions recorded at December 31, 2021 and 2020.

 

Because of net operating loss and tax credit carryforwards, substantially all of our tax years remain open and subject to examination.